Divi Coins wants to make their cryptocurrency as convenient and accessible as possible. The Divi Project is a new crypto company that closed their initial coin sale in November. The new crypto is looking to replace exchanges like Paypal or Venmo.
Geoff McCabe is the Co-founder and CEO at The Divi Project Tim Sanders is the CMO at The Divi Project. The pair joined Cheddar to explain why they think their new cryptocurrency will lead the market. Sanders stresses that as a company, Divi is attentive and responsive to their consumers' needs.
McCabe believes that in the future all cryptocurrencies will be interchangeable and exchanged via digital wallets. So for Divi, the key is to be adopted and trusted by as many people as possible. In terms of future steps, The Divi Project is looking to build out their own blockchain and wallet.
Hospital workers begin unloading precious frozen vials of COVID-19 vaccine Monday, with the first vaccinations against a scourge that has killed nearly 300,000 Americans expected later in the day.
Sen. Tina Smith (D-Minn.) joined Cheddar to discuss the need for the federal government to provide more help to states in order to effectively distribute the COVID vaccines.
Get better sleep, improve productivity and boost overall happiness with a little help from these highly-rated mindfulness picks.
Airships were once believed to be the future of human flight, so why did they fall out of favor so quickly and which flaws ultimately made them a design disaster?
Over 24 million adults in the United States have eye issues: Either you’re born with eye issues, you grow up to have eye issues, or you get so old that your eyes deteriorate into one big issue. So why are our eyes an engineering nightmare? Cheddar explains.
Make a gamer's day with the hottest accessories, subscriptions and consoles of the holiday season.
A new report shows how warming temperatures in the Arctic are transforming the region's geography and ecosystems.
Indian health officials say they have found traces of nickel and lead in a few blood samples taken from hundreds of patients who have been hospitalized by a mysterious illness in a southern state.
British regulators warned Wednesday that people who have a history of serious allergic reactions shouldn’t receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on the first day of the country’s mass vaccination program.
These seven surprises are guaranteed to top a gadget lover's holiday wish list.
